Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Review

Eph receptors in breast cancer: roles in tumor promotion and tumor suppression

David Vaught2 email, Dana M Brantley-Sieders1 email and Jin Chen1,2,3,4 email

Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

Department of Cell & Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

author email corresponding author email

Breast Cancer Research 2008, 10:217doi:10.1186/bcr2207

Published: 22 December 2008

Abstract

Eph receptor tyrosine kinase signaling regulates cancer initiation and metastatic progression through multiple mechanisms. Studies of tumor-cell-autonomous effects of Eph receptors demonstrate their dual roles in tumor suppression and tumor promotion. In addition, Eph molecules function in the tumor microenvironment, such as in vascular endothelial cells, influencing the ability of these molecules to promote carcinoma progression and metastasis. The complex nature of Eph receptor signaling and crosstalk with other receptor tyrosine kinases presents a unique challenge and an opportunity to develop therapeutic intervention strategies for targeting breast cancer.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.